Autologous CD133-Positive BTSC mRNA-Pulsed Autologous Dendritic Cell Vaccine

Known as: Autologous CD133-Positive Brain Tumor Stem Cell mRNA-Pulsed Autologous Dendritic Cell Vaccine 
A cancer vaccine consisting of autologous dendritic cells (DCs) loaded with CD133-positive autologous brain tumor stem cells (BTSCs) -derived mRNA… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2017
01220092017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND CD133-positive cells in hepatocellular carcinoma (HCC) exhibit cancer stem cell (CSC)-like properties as well as… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
In addition to intrinsic regulatory mechanisms, brain tumor stemlike cells (BTSCs), a small subpopulation of malignant glial… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 6
  • figure 7
Is this relevant?
2011
2011
Although surgery is the gold standard treatment of hepatic metastasis from colorectal cancer (CRC), many patients ultimately die… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2009
2009
CD133 was detected in several types of cancers including hepatocellular carcinoma (HCC), which raised the possibility of stem… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2009
2009
Brain tumors may arise from and contain cancer stem cells (CSCs) capable of self-renewal, proliferation, and differentiation that… (More)
Is this relevant?